NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank79
3Y CAGR+21.3%
5Y CAGR-43.2%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+21.3%/yr
Annual compound
5Y CAGR
-43.2%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.04-88.1%
20240.32+972.6%
20230.03+39.7%
20220.02-56.1%
20210.05-92.5%
20200.64-
20190.00+100.0%
2018-0.38+20.7%
2017-0.48+53.5%
2016-1.03-